← Back to Screener
Idexx Laboratories Inc (IDXX)
Price$560.73
Value ScoreD
Growth ScoreB
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-40.35%
Price vs S&P 500 (4W)-7.10%
VGM Score45.16
Market Capitalization$43.66B
P/E Ratio (Annual)41.20x
All Metrics
P/CF (Annual)36.94x
Book Value / Share (Quarterly)$19.64
P/TBV (Annual)36.12x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)8.52%
Cash Flow / Share (Quarterly)$13.48
Price vs S&P 500 (YTD)-29.97%
Gross Margin (TTM)62.05%
Net Profit Margin (TTM)24.63%
EPS (TTM)$13.59
10-Day Avg Trading Volume0.66M
EPS Excl Extra (TTM)$13.59
Revenue Growth (5Y)9.72%
EPS (Annual)$13.08
ROI (Annual)43.19%
Gross Margin (Annual)61.80%
Net Profit Margin (5Y Avg)22.76%
Cash / Share (Quarterly)$2.53
P/E Basic Excl Extra (TTM)39.86x
Revenue Growth QoQ (YoY)14.26%
EPS Growth (5Y)14.28%
P/E Normalized (Annual)41.20x
ROA (Last FY)31.62%
Revenue Growth TTM (YoY)13.08%
EBITD / Share (TTM)$19.30
ROE (5Y Avg)79.61%
Operating Margin (TTM)31.63%
Cash Flow / Share (Annual)$13.09
P/B Ratio28.05x
P/B Ratio (Quarterly)28.68x
Net Income / Employee (Annual)$96,300
EV / Revenue (TTM)9.99x
Net Interest Coverage (TTM)34.07x
ROA (TTM)32.56%
EPS Growth QoQ (YoY)17.26%
EV / EBITDA (TTM)28.58x
EPS Incl Extra (Annual)$13.08
Current Ratio (Annual)1.23x
Quick Ratio (Quarterly)0.78x
3-Month Avg Trading Volume0.56M
52-Week Price Return7.00%
EV / Free Cash Flow (Annual)42.58x
P/E Incl Extra (TTM)39.86x
Revenue / Employee (TTM)$404,200
Tangible BV / Share (Quarterly)$18.32
P/S Ratio (Annual)10.14x
Asset Turnover (Annual)1.28x
52-Week High$769.98
Operating Margin (5Y Avg)29.24%
EPS Excl Extra (Annual)$13.08
CapEx CAGR (5Y)5.08%
Tangible BV CAGR (5Y)20.88%
26-Week Price Return-26.77%
Quick Ratio (Annual)0.85x
13-Week Price Return-13.49%
Total Debt / Equity (Annual)0.53x
Current Ratio (Quarterly)1.12x
Enterprise Value$44.43B
Revenue / Share Growth (5Y)11.22%
Asset Turnover (TTM)1.32x
Book Value / Share Growth (5Y)22.18%
Revenue / Employee (Annual)$391,200
Inventory Turnover (Annual)4.33x
Pretax Margin (Annual)30.77%
Cash / Share (Annual)$2.26
3-Month Return Std Dev30.62%
Gross Margin (5Y Avg)60.19%
Net Income / Employee (TTM)$99,600
EBITDA CAGR (5Y)13.75%
EBITDA Interim CAGR (5Y)7.98%
ROE (Last FY)65.99%
Net Interest Coverage (Annual)38.48x
EPS Basic Excl Extra (Annual)$13.08
P/FCF (TTM)40.87x
Receivables Turnover (TTM)6.99x
EV / Free Cash Flow (TTM)41.60x
Total Debt / Equity (Quarterly)0.63x
EPS Incl Extra (TTM)$13.59
Receivables Turnover (Annual)7.40x
ROI (TTM)43.41%
P/S Ratio (TTM)9.82x
Pretax Margin (5Y Avg)28.37%
Revenue / Share (Annual)$53.12
Tangible BV / Share (Annual)$18.76
Forward P/E36.61x
Free OCF CAGR (5Y)14.08%
Price vs S&P 500 (52W)-21.16%
P/E Ratio (TTM)39.86x
EPS Growth TTM (YoY)25.59%
Year-to-Date Return-18.58%
5-Day Price Return-0.03%
EPS Normalized (Annual)$13.08
ROA (5Y Avg)27.96%
Net Profit Margin (Annual)24.62%
Month-to-Date Return-2.26%
Cash Flow / Share (TTM)$11.16
EBITD / Share (Annual)$18.58
EPS Growth (3Y)17.66%
Operating Margin (Annual)31.60%
LT Debt / Equity (Annual)0.23x
P/CF (TTM)36.08x
ROI (5Y Avg)38.97%
P/E Excl Extra (TTM)39.86x
LT Debt / Equity (Quarterly)0.19x
EPS Basic Excl Extra (TTM)$13.59
P/TBV (Quarterly)30.75x
P/B Ratio (Annual)33.65x
Inventory Turnover (TTM)4.33x
Pretax Margin (TTM)30.80%
Book Value / Share (Annual)$20.14
Price vs S&P 500 (13W)-24.15%
Net Margin Growth (5Y)2.76%
Beta1.55x
P/FCF (Annual)41.83x
Revenue / Share (TTM)$55.46
ROE (TTM)70.87%
52-Week Low$504.56
vGradeD
gGradeB
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 263.47est. 3.47
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.05
4.05
4.05
3.96
Industry Peers — In Vitro Diagnostics(18)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IDXXIdexx Laboratories Inc | D | B | C | $560.73 |
| LNTHLantheus Holdings, Inc | C | B | B | $100.25 |
| NNNNAnbio Biotechnology Class A Ordinary Shares | F | B | A | $28.51 |
| CLDXCelldex Therapeutics, Inc | F | F | C | $29.77 |
| NEOGNeogen Corp | C | C | C | $8.81 |
| NTLAIntellia Therapeutics, Inc | D | C | B | $13.02 |
| QDELQuidelOrtho Corporation Common Stock | C | C | D | $13.60 |
| ACHVAchieve Life Sciences, Inc. | F | F | B | $4.92 |
| MYGNMyriad Genetics Inc | C | C | C | $4.40 |
| TKNOAlpha Teknova, Inc. Common Stock | C | C | B | $5.13 |
| IMDXInsight Molecular Diagnostics Inc. Common Stock | F | D | B | $6.03 |
About
IDEXX Laboratories is a leading provider of diagnostic solutions and practice management software for veterinary and livestock producers. The company offers in-clinic diagnostic test kits, laboratory analyzers, reference laboratory services, and veterinary practice management software that enable disease detection and management. With approximately 35% of revenues derived outside the United States, IDEXX operates across both domestic and international veterinary markets.